Suppr超能文献

腹膜透析患者钠清除、水合与结局的关系。

Relationship between sodium removal, hydration and outcomes in peritoneal dialysis patients.

机构信息

Departments of Renal Medicine and Transplantation, Barts Health NHS Trust, London, United Kingdom.

Department of Clinical Biochemistry, Barts Health NHS Trust, London, United Kingdom.

出版信息

Nephrology (Carlton). 2021 Aug;26(8):676-683. doi: 10.1111/nep.13885. Epub 2021 Apr 30.

Abstract

BACKGROUND

Fluid overload (FO) in peritoneal dialysis (PD) patients is associated with mortality. We explore if low daily sodium removal is an independent risk factor for mortality. We examined severely FO PD patients established for >1 year in expectation that PD prescription would have been optimized for solute clearance and ultrafiltration. We also wish to determine the relationship between kt/v and sodium removal.

METHODS

Retrospective analysis of 231 PD patients with FO ≥2.0 L and compared with 218 PD patients who were euvolaemic throughout their PD treatment. Patients were followed up until death censored for transplantation.

RESULTS

Mean daily sodium removal in overhydrated patients was only 75 mmoles (=1.7 g). CAPD usage was more common in patients with the highest sodium removal. Achievement of UK guidelines for solute clearance and daily fluid removal were not independent predictors of mortality. Markers of sarcopenia (low serum albumin and high CRP) were associated with increased mortality, but these parameters were not independent predictors in a model that included functional assessment (Karnofsky score). Daily sodium removal was not predictive of mortality but the imprecision of clinically used sodium assay should be noted. The correlation between Na and kt/v is statistically significant but R was weak at .07.

CONCLUSION

While diabetic males were more likely to become overhydrated, these factors did not increase mortality further. Traditional targets of 'dialysis adequacy' did not predict survival. Kt/v is not a good indicator of sodium removal which can be surprisingly low. Measuring sodium clearance may help clinicians optimize PD modality (CAPD vs. APD).

摘要

背景

腹膜透析(PD)患者的液体超负荷(FO)与死亡率相关。我们探讨低每日钠清除是否是死亡率的独立危险因素。我们检查了已接受 PD 治疗>1 年的严重 FO PD 患者,预期 PD 处方已针对溶质清除和超滤进行了优化。我们还希望确定 kt/v 与钠清除之间的关系。

方法

回顾性分析了 231 例 FO≥2.0 L 的 PD 患者,并与 218 例整个 PD 治疗期间均为血容量正常的 PD 患者进行比较。患者随访至死亡或移植截止。

结果

过度水化患者的平均每日钠清除量仅为 75 毫摩尔(=1.7 克)。在钠清除量最高的患者中,使用持续不卧床腹膜透析(CAPD)的情况更为常见。达到英国溶质清除和每日液体清除指南标准并不是死亡率的独立预测因素。肌肉减少症(低血清白蛋白和高 C 反应蛋白)标志物与死亡率增加相关,但这些参数在包括功能评估(卡诺夫斯基评分)的模型中不是独立的预测因素。每日钠清除量与死亡率无关,但应注意临床使用的钠测定法不精确。Na 与 kt/v 之间的相关性具有统计学意义,但 R 值仅为 0.07,较弱。

结论

虽然男性糖尿病患者更容易发生液体超负荷,但这些因素并未进一步增加死亡率。传统的“透析充分性”目标并不能预测生存。kt/v 不是钠清除的良好指标,其值可能低得令人惊讶。测量钠清除率可能有助于临床医生优化 PD 方式(CAPD 与 APD)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验